Browsing Cancer Therapeutics by author "Carotenuto, Pietro"
Now showing items 1-4 of 4
-
Characterisation of the immune-related transcriptome in resected biliary tract cancers.
Ghidini, M; Cascione, L; Carotenuto, P; Lampis, A; Trevisani, F; et al. (ELSEVIER SCI LTD, 2017-11-01)UNLABELLED: Although biliary tract cancers (BTCs) are known to have an inflammatory component, a detailed characterisation of immune-related transcripts has never been performed. In these studies, nCounter PanCancer Immune ... -
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.
Lampis, A; Carotenuto, P; Vlachogiannis, G; Cascione, L; Hedayat, S; et al. (W B SAUNDERS CO-ELSEVIER INC, 2018-03-01)BACKGROUND & AIMS: Cholangiocarcinomas (CCA) are resistant to chemotherapy, so new therapeutic agents are needed. We performed a screen to identify small-molecule compounds that are active against CCAs. Levels of microRNA ... -
Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Previdi, MC; Carotenuto, P; Zito, D; Pandolfo, R; Braconi, C (FUTURE MEDICINE LTD, 2017-02-01)Pancreatic cancer is an aggressive cancer of the digestive system, which is becoming a serious health problem worldwide. Overall survival for patients with pancreatic cancer is poor, mainly due to a lack of biomarkers to ... -
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
Carotenuto, P; Fassan, M; Pandolfo, R; Lampis, A; Vicentini, C; et al. (BMJ PUBLISHING GROUP, 2016-09-14)OBJECTIVE: Transcribed-ultraconserved regions (T-UCR) are long non-coding RNAs which are conserved across species and are involved in carcinogenesis. We studied T-UCRs downstream of the Wnt/β-catenin pathway in liver cancer. ...